Table 2

Distribution of arterial cardiovascular events and (recurrent) venous thromboembolic events during the follow-up period

Total population, n (%)Control population, n (%)Patients with provoked PE, n (%)Patients with unprovoked PE, n (%)RR patients vs controls
RR unprovoked PE vs controls
RR provoked PE vs controls
RR unprovoked vs provoked PE
RR95% CIRR95% CIRR95% CIRR95% CI
Any arterial cardiovascular event 63 (5.1) 26 (4.1) 17 (3.4) 20 (13) 1.34 0.83-2.2 2.70 1.6-4.6 0.84 0.47-1.5 3.21 1.8-5.8 
Myocardial infarction 14 (0.89) 4 (0.31) 4 (0.40) 6 (4.2) 2.35 0.93-6.0 5.27 1.9-14 1.29 0.42-4.0 4.09 1.5-11 
Stroke 21 (1.3) 6 (0.87) 6 (0.92) 9 (3.7) 2.35 0.93-6.0 5.27 1.9-14 1.29 0.42-4.0 4.09 1.5-11 
Other 28 (2.9) 16 (2.9) 7 (2.1) 5 (5.0) 0.71 0.34-1.5 1.10 0.41-2.9 0.56 0.24-1.4 1.95 0.63-6.0 
(Recurrent) VT 37 (6.0) 8 (1.8) 17 (8.4) 12 (16) 3.42 1.6-7.4 5.27 2.2-13 2.74 1.2-6.3 1.92 0.96-3.9 
Total population, n (%)Control population, n (%)Patients with provoked PE, n (%)Patients with unprovoked PE, n (%)RR patients vs controls
RR unprovoked PE vs controls
RR provoked PE vs controls
RR unprovoked vs provoked PE
RR95% CIRR95% CIRR95% CIRR95% CI
Any arterial cardiovascular event 63 (5.1) 26 (4.1) 17 (3.4) 20 (13) 1.34 0.83-2.2 2.70 1.6-4.6 0.84 0.47-1.5 3.21 1.8-5.8 
Myocardial infarction 14 (0.89) 4 (0.31) 4 (0.40) 6 (4.2) 2.35 0.93-6.0 5.27 1.9-14 1.29 0.42-4.0 4.09 1.5-11 
Stroke 21 (1.3) 6 (0.87) 6 (0.92) 9 (3.7) 2.35 0.93-6.0 5.27 1.9-14 1.29 0.42-4.0 4.09 1.5-11 
Other 28 (2.9) 16 (2.9) 7 (2.1) 5 (5.0) 0.71 0.34-1.5 1.10 0.41-2.9 0.56 0.24-1.4 1.95 0.63-6.0 
(Recurrent) VT 37 (6.0) 8 (1.8) 17 (8.4) 12 (16) 3.42 1.6-7.4 5.27 2.2-13 2.74 1.2-6.3 1.92 0.96-3.9 

PE indicates pulmonary embolism; and RR, relative risk.

Close Modal

or Create an Account

Close Modal
Close Modal